Results for &quot;&quot;Caspofungin&quot;&quot;[mesh_terms]

Caspofungin: a review of its characteristics, activity, and use in intensive care units.

Ali Akbar Velayati, Seyed MohammadReza Hashemian, Tayebeh Farhadi

Expert review of anti-infective therapy 2021;18(12):1213-1220

Natural products targeting the synthesis of β(1,3)-D-glucan and chitin of the fungal cell wall. Existing drugs and recent findings.

M Ángeles Curto, Estefanía Butassi, Juan C Ribas, Laura A Svetaz, Juan C G Cortés

Phytomedicine : international journal of phytotherapy and phytopharmacology 2021;88():153556

Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.

Francine Perrine-Walker

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] 2022;53(3):1101-1113

Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin.

R E Gardiner, P Souteropoulos, S Park, D S Perlin

Medical mycology 2005;43 Suppl 1():S299-305

Biomarkers of caspofungin resistance in isolates: A proteomic approach.

Giuseppe Buda De Cesare, Ahmed Hafez, David Stead, Carlos Llorens, Carol A Munro

Virulence 2022;13(1):1005-1018

Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis.

A H Groll, A Tragiannidis

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2009;15 Suppl 5():82-6

Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in a Clinical Practice Setting in China.

Xiaohui Zhang, Jiong Hu, Yu Hu, He Huang, Jie Jin, Juan Li, Qifa Liu, Zonghong Shao, Jianxiang Wang, Quanshun Wang, Depei Wu, Xiaojun Huang

Clinical therapeutics 2018;39(9):1758-1768

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature.

G Kofla, Markus Ruhnke

European journal of medical research 2011;16(4):159-66

Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.

Andrew J Ullmann

Current medical research and opinion 2003;19(4):263-71

New antifungal agents.

Aditya K Gupta, Elizabeth Tomas

Dermatologic clinics 2003;21(3):565-76

Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.

Julie A Stone, Sherry D Holland, Peter J Wickersham, Andrew Sterrett, Michael Schwartz, Cynthia Bonfiglio, Michael Hesney, Gregory A Winchell, Paul J Deutsch, Howard Greenberg, Thomas L Hunt, Scott A Waldman

Antimicrobial agents and chemotherapy 2002;46(3):739-45

Echinocandin antifungal drugs.

David W Denning

Lancet (London, England) 2003;362(9390):1142-51

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis.

Michaela Döring, Ulrike Hartmann, Annika Erbacher, Peter Lang, Rupert Handgretinger, Ingo Müller

BMC infectious diseases 2013;12():151

Caspofungin.

G M Keating, B Jarvis

Drugs 2001;61(8):1121-9; discussion 1130-1